Experts from Hokkaido University have carried out a series of experiments using mice suffering from the type of cancer that has metastasized to the liver, lungs, and bones. Based on the results of the study, the researchers concluded that the use of injectable flufenamic acid can lead to good results in the treatment of oncological diseases of the bladder.

The authors say the experiments: "This method is able to stop the spread of bladder cancer." Recall that this type of cancer is the seventh in the world the extent of cancer in men form.

Experts explained that the disease can be grouped into two types: non-muscle-invasive cancer and the musculo-invasive cancer, the first appearance is characterized by a 5-year survival rate of patients in 90% of cases, and the second - fleeting tragic outcome. Cisplatin is assigned, but the disease typically becomes resistant to chemotherapy and metastasize to other organs in the therapy of muscle-invasive cancers.

Scientists in Japan have established: flufenamic acid helps break down such resistance. Typically, this preparation, which is a non-steroidal anti-inflammatory drug used for the treatment of colds, osteoarthritis, ankylosing spondylitis and rheumatoid arthritis. "Our research has shown that the use of injectable flufenamic acid can suppress the invasive activity of cells. In this restored efficacy against cancer ", - the authors of innovations reported.